title: Physico-chemical characterization and in vitro/in vivo evaluation of loratadine:dimethyl-β-cyclodextrin inclusion complexes.
abstract: A tricyclic, piperidine derivative of antihistamines, loratadine, which belongs in class II of the Biopharmaceutical Classification System, was investigated. It is an ionizable drug, whose solubility depends on the gastrointestinal pH, and the bioavailability is therefore very variable. Inclusion complexes were prepared by kneading method, containing loratadine (LOR) and dimethyl-β-cyclodextrin (DIMEB) in two different molar ratios in an attempt to achieve better dissolution and therefore the better bioavailability of loratadine. The formation and physicochemical properties of the inclusion complexes were investigated by means of dissolution tests, pH-dependent solubility studies, electrospray ionization mass spectrometry and diffusion-ordered 1H NMR spectroscopy. The in vivo efficiency of the complexes was examined in rat animal experiments to confirm the better in vitro dissolution. The instrumental examinations proved the presence of total complexes in 1:1 ratio in both compositions. However, the in vitro pH-dependent solubility results, the in vivo blood levels and the greater pharmacological effect prove that excess DIMEB is needed to achieve the pH-independent and complete solubility of LOR, and therefore better and more consistent bioavailability.
authors.affiliation: Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Szeged, H-6720, Eötvös u. 6, Szeged, Hungary.
authors.forename: A
authors.initials: A
authors.lastname: Szabados-Nacsa
authors.forename: P
authors.initials: P
authors.lastname: Sipos
authors.forename: T
authors.initials: T
authors.lastname: Martinek
authors.forename: I
authors.initials: I
authors.lastname: Mándity
authors.forename: G
authors.initials: G
authors.lastname: Blazsó
authors.forename: Á
authors.initials: Á
authors.lastname: Balogh
authors.forename: P
authors.initials: P
authors.lastname: Szabó-Révész
authors.forename: Z
authors.initials: Z
authors.lastname: Aigner
mesh_terms: D000818:Animals; D001682:Biological Availability; D002851:Chromatography, High Pressure Liquid; D039563:Histamine H1 Antagonists, Non-Sedating / Q000737:chemistry* / Q000493:pharmacokinetics / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D017336:Loratadine / Q000737:chemistry* / Q000493:pharmacokinetics / Q000494:pharmacology*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D012995:Solubility; D021241:Spectrometry, Mass, Electrospray Ionization; D047392:beta-Cyclodextrins / Q000737:chemistry*
chemical_list: D039563:Histamine H1 Antagonists, Non-Sedating; D047392:beta-Cyclodextrins; C038119:heptakis(2,6-O-dimethyl)beta-cyclodextrin; D017336:Loratadine